Skip to main content
logo
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
12.25
+1.00 (8.89%)
Nov 6, 2026, 4:00 PM EST - Market closed

4D Molecular Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
677429257866719705
Market Cap Growth
37.87%66.42%-70.27%20.40%2.03%-35.79%
Enterprise Value
28579-268562497478
Last Close Price
12.257.505.5720.2622.2121.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.365.036959.1441.80229.9339.09
PB Ratio
1.660.850.502.813.112.21
P/TBV Ratio
1.660.850.502.813.112.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.100.92-27.10158.8926.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.100.040.050.050.070.05
Net Debt / Equity Ratio
-0.96-0.97-0.94-0.92-0.87-0.94
Net Debt / EBITDA Ratio
2.073.252.632.621.884.28
Net Debt / FCF Ratio
2.514.493.483.622.063.82
Asset Turnover
0.190.1500.070.010.06
Quick Ratio
7.689.1514.5815.2113.5815.21
Current Ratio
8.039.3914.9215.6514.0215.69
Return on Equity (ROE)
-43.25%-27.57%-39.31%-37.41%-39.06%-24.79%
Return on Assets (ROA)
-25.09%-17.34%-26.08%-23.45%-22.35%-13.89%
Return on Capital Employed (ROCE)
-43.60%-29.90%-35.40%-35.20%-44.70%-21.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.64%-32.70%-62.48%-11.64%-14.94%-10.11%
FCF Yield
-23.05%-25.58%-53.74%-9.07%-13.65%-11.10%
Buyback Yield / Dilution
-15.93%-7.39%-37.86%-20.95%-16.66%-331.23%
SEC Filings: 10-K · 10-Q